INTHERA BIOSCIENCE
Inthera Bioscience is a Switzerland-based private biopharmaceutical company developing targeted small molecule therapies for solid tumors. It is focused on developing inhibitors of intracellular protein-protein interactions employing a proprietary technology platform. The company is headquartered in Zürich, Switzerland.
INTHERA BIOSCIENCE
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2013-01-01
Address:
Schlieren, Zurich, Switzerland
Country:
Switzerland
Website Url:
http://www.intherabio.com
Total Employee:
11+
Status:
Active
Total Funding:
20.06 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API LetsEncrypt Apple Mobile Web Clips Icon WordPress Wordpress Plugins IPv6 Microsoft LiteSpeed
Similar Organizations
AbCheck s.r.o.
AbCheck s.r.o provides a unique source of therapeutic antibodies with one of the industry's most versatile technology platforms.
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Apex Molecular
Apex Molecular is a provider of specialist chemistry services to the pharmaceutical, biotechnology, and applied chemistry sectors.
Aprea
Aprea is a biopharmaceutical company that develops novel cancer therapeutics.
Arvinas
Arvinas advances therapies degrading disease-causing proteins for life-threatening diseases, from discovery to commercialization.
Aura Biosciences
Aura Biosciences is a biotechnology company that focuses on the development of drugs by using tumor targeted pseudovirions.
Bioithas
Bioithas research is directed at obtaining unique biotechnological results, generating projects with real value.
Carlina Technologies
Company specialized in the development of nanomedicines utilizing innovative controlled drug delivery technology platforms.
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
ExtremoChem
ExtremoChem develops small organic molecules, obtained exclusively by chemical synthesis, with protein stabilizing properties.
Feroscan
Development of 1st-in-class personalized organometallic with a unique & innovative mode of action coupled with nanoparticle
Hoba Therapeutics
Hoba Therapeutics is developing a new therapeutic protein for the treatment of neuropathic pain.
HQS Quantum Simulations
HQS Quantum Simulations is developing quantum algorithms to predict molecular properties for specialty chemicals & pharmaceutical companies.
Icon Bioscience
Icon Bioscience develops and commercializes novel ophthalmic pharmaceuticals through a proprietary drug delivery platform.
Libera Bio
Addressing “undruggable intracellular targets” in oncology
Metis Precision Medicine
Metis Precision Medicine is a B-Corp founded with the vision of bringing powerful cancer therapies to patients in need.
NanoTemper Technologies
NanoTemper builds tools for challenging characterizations: affinity screening, molecular interactions, protein stability, or protein quality
Osteolabs
Osteolabs brings the possibility for a bone density study significantly ahead in time.
Peptomyc
Peptomyc focuses on the development of a new generation of cell-penetrating peptides targeting the Myconcoprotein for cancer treatment.
Prescient Healthcare Group
Prescient Healthcare Group was founded in London in 1995, originally specializing in competitive insights.
QuantuMDx Group
QuantuMDx is a medical devices company developing handheld and portable diagnostic, genomic sequencing, and proteomic platforms.
Resolve BioSciences
Resolve Biosciences is applying the power of Molecular Cartography to enable scientists to gain new insights in spatial biology.
RS Research
RS Research is a pharmaceutical company developing next generation of nanomedicines based on an innovative drug delivery platform.
Scope Biosciences
Scope Biosciences is a on-site development platform technology specializing in the development of molecular diagnostics using CRISPR-Cas.
STipe Therapeutics
STipe Therapeutics focuses on harnessing the innate immune system to battle cancer.
Current Advisors List
Current Employees Featured
Founder
Investors List
Aglaia BioMedical Ventures
Aglaia BioMedical Ventures investment in Series A - Inthera Bioscience
M Ventures
M Ventures investment in Series A - Inthera Bioscience
Novo Holdings
Novo Holdings investment in Series A - Inthera Bioscience
M Ventures
M Ventures investment in Series A - Inthera Bioscience
Novo Holdings
Novo Holdings investment in Series A - Inthera Bioscience
Aglaia BioMedical Ventures
Aglaia BioMedical Ventures investment in Series A - Inthera Bioscience
EVA Basel
EVA Basel investment in Seed Round - Inthera Bioscience
Novo Holdings
Novo Holdings investment in Seed Round - Inthera Bioscience
Microsoft Accelerator
Microsoft Accelerator investment in Seed Round - Inthera Bioscience
Aglaia BioMedical Ventures
Aglaia BioMedical Ventures investment in Seed Round - Inthera Bioscience
Official Site Inspections
http://www.intherabio.com
- Host name: linux31.curanet.dk
- IP address: 185.21.41.237
- Location: Denmark
- Latitude: 55.7123
- Longitude: 12.0564
- Timezone: Europe/Copenhagen
More informations about "Inthera Bioscience"
Inthera Bioscience - Crunchbase Company Profile
Inthera Bioscience is a Switzerland-based private biopharmaceutical company developing targeted small molecule therapies for solid tumors. It is focused on …See details»
Inthera Bioscience - Overview, News & Similar companies
Who is Inthera Bioscience. Inthera Bioscience is a private biopharmaceutical company focused on developing inhibitors of intracellular protein-protein interactions employing a proprietary …See details»
Inthera Bioscience AG Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Inthera Bioscience AG of Zürich, ZÜRICH. Get the latest business insights from Dun & Bradstreet.See details»
Inthera Bioscience AG: Contact Details and Business Profile
What is the NAICS code for Inthera Bioscience AG? The NAICS codes for Inthera Bioscience AG are [5417, 54171, 54, 541714, 541].See details»
Inthera Bioscience AG Management Team | Org Chart
Looking for a particular Inthera Bioscience AG employee's phone or email?. Find Info Top Inthera Bioscience AG Management EmployeesSee details»
Inthera Bioscience - Craft
Inthera Bioscience $20.02 m in total funding,. See insights on Inthera Bioscience including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Inthera Bioscience - Products, Competitors, Financials, Employees ...
Intherabio.com. Overview & Products; Financials; People; Stage Series A | Alive. Total Raised $14.8M. Last Raised $11.1M | 7 yrs ago. About Inthera Bioscience. Inthera Bioscience is a …See details»
Inthera Bioscience AG - Drug pipelines, Patents, Clinical trials
Aug 2, 2024 Explore Inthera Bioscience AG with its drug pipeline, therapeutic area, technology platform, , Drug:INTH-454.See details»
Inthera Biosciences - VentureRadar
Website: http://intherabio.com/ Develops novel therapeutics targeting intracellular protein-protein interactions using a proprietary technology platform, with an ...See details»
Inthera – Funding, Valuation, Investors, News
Nov 8, 2022 Inthera Bioscience is an emerging Swiss biotechnology company that develops innovative and highly effective therapies against currently incurable cancers. The company is …See details»
Inthera Bioscience - CoBee Company Profile & Funding Rounds
Inthera Bioscience is a Switzerland-based private biopharmaceutical company developing targeted small molecule therapies for solid tumors. It is focused on developing inhibitors of …See details»
Inthera Bioscience Ag - Zürich 8050 (Bezirk Zürich ... - Kompass
Login Welcome to Kompass Global B2B portal where Buyers can find and contact the best product or service Suppliers! The Kompass B2B portal helps buyers and reliable suppliers …See details»
Inthera Bioscience AG – Swiss Biotech
Private biotech company focused on developing modulators of intracellular protein-protein interactions employing a proprietary technology platform. The most advanced of these first-in …See details»
Inthera Bioscience AG - BioCentury Company Profiles - BCIQ
Inthera Bioscience AG - BioCentury Company Profiles for the biopharma industrySee details»
Inthera Bioscience - PitchBook
Inthera Bioscience General Information Description. Developer of targeted small molecule therapies designed to treat solid tumors. The company's therapies are focused on the …See details»
Inthera Bioscience - Contacts, Employees, Board Members
Organization. Inthera Bioscience . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 4. Number of …See details»
Inthera Bioscience AG expands management team with seasoned ...
Jun 26, 2018 [email protected] Phone: +41 43 477 94 66. Return to overview. Home > News > Inthera Bioscience AG expands management team w... Contact. …See details»
Intherabio Security Rating - SecurityScorecard
View Intherabio's cyber security risk rating against other vendors' scores. Explore cyber risks, data breaches, and cybersecurity incidents involving IntherabioSee details»
Home - IntraBio
IntraBio is a leader in discovering, developing, and commercializing novel therapies and treatments for rare and neurodegenerative diseases with high unmet medical needs.See details»
Destruction, Injuries After Russian Missile Attack in Ukraine's Kryviy ...
2 days ago At least five people were injured as private and municipal buildings were damaged or completely destroyed in a massive Russian missile attack that also targeted Ukraine's capital, …See details»